Guang Shu

6.1k total citations · 2 hit papers
66 papers, 3.8k citations indexed

About

Guang Shu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guang Shu has authored 66 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Guang Shu's work include Epigenetics and DNA Methylation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related gene regulation (9 papers). Guang Shu is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related gene regulation (9 papers). Guang Shu collaborates with scholars based in China, United States and United Kingdom. Guang Shu's co-authors include Gang Yin, Yulong Peng, Liuer He, Qing Xiao, Anqi Wu, Huiyu Li, Zhengwei Zhou, Jiani Xiao, Yuanyuan Li and Jiaqi Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Guang Shu

63 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

2022 1.3k citations Jiaqi Liu, Qing Xiao et al. Signal Transduction and Targeted Therapy profile →
Functions of N6-methyladenosine and its role in cancer

2019 997 citations Anqi Wu, Yulong Peng et al. profile →

Peers

Countries citing papers authored by Guang Shu

Since Specialization

Citations

This map shows the geographic impact of Guang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Shu more than expected).

Fields of papers citing papers by Guang Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Shu. The network helps show where Guang Shu may publish in the future.

Co-authorship network of co-authors of Guang Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Guang Shu. A scholar is included among the top collaborators of Guang Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guang Shu. Guang Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic reprogramming in cancer and senescence 2025 ·MedComm ·Yuzhu Zhang, (unknown), Can Jiang, (unknown), Guang Shu, Gang Yin, Maonan Wang	5
2	State shareholding in privately-owned firms and greenwashing: Evidence from China 2024 ·Finance research letters ·(unknown), Zhong Ma, (unknown), Guang Shu	7
3	Miniscrew anchorage versus Class II elastics for maxillary arch distalization using clear aligners 2024 ·The Angle Orthodontist ·Fen Liu, Jian Liu, (unknown), (unknown), Guang Shu, Fanfan Dai	5
4	Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer 2024 ·Aging ·Chenxi Niu, (unknown), Shutong Wang, Guang Shu, Maonan Wang, (unknown), Ke Guo, Qiong Pan, Gang Yin	3
5	The Role of the CPT Family in Cancer: Searching for New Therapeutic Strategies 2024 ·Biology ·Yong Duan, Jiaxin Liu, Ailin Li, Chang Liu, Guang Shu, Gang Yin	2
6	How accurate is predicted root movement achieved in four first‐premolar extraction cases with Invisalign? 2024 ·Orthodontics and Craniofacial Research ·Fanfan Dai, (unknown), (unknown), Hongjian Wang, (unknown), (unknown), Tianmin Xu, Guang Shu	5
7	HDAC5, negatively regulated by miR‐148a‐3p, promotes colon cancer cell migration 2022 ·Cancer Science ·(unknown), Guang Shu, Jiaxin Liu, Shumin Deng, (unknown), Yimin Li, Yaqi Gan, (unknown), Junwen Liu, Gang Yin	8
8	Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction 2022 ·Cell Death and Disease ·Qing Xiao, Jiani Xiao, Jiaqi Liu, Jiaxin Liu, Guang Shu, Gang Yin	54
9	Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities breakdown → 2022 ·Signal Transduction and Targeted Therapy ·Jiaqi Liu, Qing Xiao, Jiani Xiao, Chenxi Niu, Yuanyuan Li, Xiaojun Zhang, Zhengwei Zhou, Guang Shu, Gang Yin	1348
10	Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells 2022 ·Frontiers in Immunology ·Fei Gao, Zhengwei Zhou, Ying Lin, Guang Shu, Gang Yin, Tianxiang Zhang	11
11	Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis 2022 ·Cellular and Molecular Life Sciences ·Lili Fan, Lei Han, Ying Lin, Zhengwei Zhou, Juanni Li, Anqi Wu, Guang Shu, Sébastien Roger, Gang Yin	10
12	TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells 2022 ·Scientific Reports ·Jiaqi Liu, Guang Shu, Anqi Wu, Xiaojun Zhang, Zhengwei Zhou, Ayesha B. Alvero, Gil Mor, Gang Yin	7
13	Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining 2021 ·Frontiers in Molecular Biosciences ·Lili Fan, Lei Han, Ying Lin, Zhengwei Zhou, Guang Shu, Zhipeng Yan, Haotian Chen, Tianxiang Zhang, Gang Yin	15
14	HOXC10 promotes tumour metastasis by regulating the EMT-related gene Slug in ovarian cancer 2020 ·Aging ·Yulong Peng, Yuanyuan Li, Yimin Li, Anqi Wu, Lili Fan, Wenli Huang, Chunyan Fu, Zhenghao Deng, Kuansong Wang, Yu Zhang, Guang Shu, Gang Yin	20
15	Synthesis of Fe-Al Pillared Bentonite and Heterogeneous Fenton Degradation of Orange Ⅱ 2013 ·Acta Physico-Chimica Sinica ·Dong Wan, Guanghua Wang, Wenbing Li, Kun Chen, Guang Shu	3
16	A Comparative Study of Escitalopram and Citalopram in the Treatment of Depression 2012 ·Guang Shu	1
17	A two-stage reconstruction approach for seeing through water 2011 ·Journal of International Crisis and Risk Communication Research ·Omar Oreifej, Guang Shu, (unknown), Mubarak Shah	41
18	Research on Vision-Action Model of Autonomous Robot and Obstacle Avoiding 2003 ·Dianzi xuebao ·Guang Shu	2
19	Purification, Crystallization And Preliminary X-Ray Studies Of A P- Nitrophenylphosphatase From Bacillus Stearothermophilus 2003 ·Protein and Peptide Letters ·Chaoneng Ji, (unknown), (unknown), Gang Yin, Guang Shu, Jixi Li, (unknown), (unknown), (unknown), Yumin Mao	1
20	Meta-synthetic system reconstruction and applications in macro-economic researches 2001 ·Journal of systems engineering ·Guang Shu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact